Spin-out raises £2.4m for early cancer detection test
A university spin-out which has developed a way to detect cancer at an early stage using a simple blood test has completed a £2.4m funding round led by Mercia’s EIS funds. The investment will allow ClinSpec Diagnostics (ClinSpec Dx) to further develop its technology and expand its team. The Glasgow-based company was founded in 2016 to commercialise research